CorVel Corporation — Form 10-Q Summary
Period: Three months ended June 30, 2023, compared with the three months ended June 30, 2022. This is fiscal 2024 first quarter; the request metadata’s “2022 Q1” does not match the filing period.
Business context
CorVel provides managed-care and medical cost-containment services, primarily for workers’ compensation, auto insurance, and group health claims. It reports one operating segment. Revenue comes from patient management and network solutions services.
Financial performance
| Metric | Q1 FY2024 | Comparable quarter | Change |
|---|---|---|---|
| Revenue | $190.3 million | $176.3 million | +7.9% |
| Gross profit | $41.9 million | $39.9 million | +5.0% |
| Gross margin | 22.0% | 22.6% | Down 0.6 percentage points |
| General and administrative expense | $16.5 million | $18.7 million | Down 11.9% |
| Income before tax | $25.4 million | $21.2 million | +20.0% |
| Net income | $19.8 million | $16.7 million | +18.7% |
| Diluted EPS | $1.14 | $0.94 | +21.3% |
| Operating cash flow | $36.6 million | $30.0 million | + $6.6 million |
Patient management revenue rose 11.3% to $127.8 million, and network solutions revenue increased 1.5% to $62.4 million. Patient management accounted for 67.2% of revenue, versus 65.1% a year earlier. New claims increased 9% year over year. Pretax margin improved to 13.4% from 12.0%, while higher service delivery costs, including wage and staffing increases, weighed on gross margin. The effective tax rate was 22.0%, compared with 21.3%.
Cash, liquidity, and capital
- Cash and cash equivalents were $86.6 million at June 30, 2023, up from $71.3 million at March 31, 2023. Working capital was $80.2 million, versus $75.9 million.
- Operating cash flow was $36.6 million; capital spending was $5.0 million; treasury-stock purchases were $17.8 million. Cash increased by $15.3 million during the quarter.
- The company reported no debt outstanding. Operating and finance lease liabilities totaled $32.2 million; approximately $7.3 million of additional operating lease commitments had not yet commenced.
- CorVel repurchased 87,992 shares for approximately $17.8 million during the quarter, at a reported average price of about $201 per share. It repurchased a further 10,493 shares for $2.1 million after quarter-end.
Changes, outlook, and risks
Revenue growth was driven mainly by patient management activity with existing and new customers. Cost of revenues grew faster than revenue, reflecting higher volume, 5.7% growth in average field headcount, and wage inflation. G&A expense was lower year over year; management attributes the decrease primarily to a one-time insurance recovery settlement relating to a 2011 lawsuit, though the filing’s description does not clearly identify the timing of that item. Management expects G&A expense in future quarters to return to 10%–12% of revenue.
Management stated that cash and operating cash generation should fund obligations, share repurchases, new services, and development for at least the next 12 months. It may reduce or suspend repurchases if income or cash flow falls. No specific revenue or earnings guidance was provided. The filing cautions that quarterly results are not necessarily indicative of full-year results.
Risks highlighted include changes in workers’ compensation claims and outsourcing demand, customer retention and competition, labor and benefit inflation, technology development and cybersecurity, regulatory and privacy changes, and litigation or liability exposure. The company said ordinary-course litigation is not expected to result in material payments. It also noted inflation may materially affect pricing and operating expenses in future periods. Indemnification obligations under certain contracts are not readily estimable; no material liability was recorded for them.
Important facts for investors to verify
- Confirm the filing period: June 30, 2023 quarter, rather than 2022 Q1 as specified in the request metadata.
- Assess whether patient management growth and new-claim trends continue, and whether network solutions growth improves.
- Track gross margin, wage inflation, staffing costs, and the return of G&A to management’s stated 10%–12% range, including the effect of the one-time insurance recovery.
- Monitor operating cash conversion and the pace and price of share repurchases relative to cash generation and liquidity.
- Review customer concentration and renewal exposure, cybersecurity and regulatory developments, and lease commitments alongside the absence of debt.